Početna › Difuzni veliki B-stanični limfom › Tennessee › Nashville
Kliničke studije za Difuzni veliki B-stanični limfom u gradu Nashville, TN
15 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Nashville i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
U tijeku regrutacijaFaza 2
- Vanderbilt University Medical Center, Nashville
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
U tijeku regrutacijaFaza 2
- Vanderbilt University/Ingram Cancer Center, Nashville
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
U tijeku regrutacijaFaza 1/2
- Tennessee Oncology, Pllc Nashville, Nashville
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
U tijeku regrutacijaFaza 1/2
- SCRI Oncology Partners ( Site 0100), Nashville
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
U tijeku regrutacijaFaza 2
- SCRI Oncology Partners ( Site 7002), Nashville
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
U tijeku regrutacijaFaza 1
- Sarah Cannon Research Institute, Nashville
- Vanderbilt University Medical Center, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
U tijeku regrutacijaFaza 1
- SCRI Oncology Partners, Nashville
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
U tijeku regrutacijaFaza 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
U tijeku regrutacijaFaza 2
- Tennessee Oncology, Nashville
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
U tijeku regrutacijaFaza 1/2
- Sarah Cannon Research Institute, Nashville
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- Vanderbilt University Medical Center, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
U tijeku regrutacijaFaza 1/2
- TriStar BMT, Nashville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
U tijeku regrutacijaFaza 3
- SCRI Oncology Partners, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
U tijeku regrutacijaFaza 2
- SCRI Oncology Partners, Nashville
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
- Tennessee Oncology, Nashville
Studije za Difuzni veliki B-stanični limfom u drugim gradovima
- New York City, NY21 studija
- Baldwin Park, CA19 studija
- Chicago, IL18 studija
- Houston, TX17 studija
- Los Angeles, CA17 studija
- Boston, MA16 studija
- Milwaukee, WI16 studija
- Portland, OR15 studija
- Philadelphia, PA15 studija
- Durham, NC14 studija
- Dallas, TX13 studija
- Seattle, WA12 studija
Ostale studije u gradu Nashville
- Nemikrocelularni karcinom pluća97 studija
- Rak dojke80 studija
- Metastatski karcinom70 studija
- Kolorektalni rak69 studija
- Rak (sve vrste)65 studija
- Rak jajnika49 studija
- Rak prostate42 studija
- Rak pluća40 studija
- Pločastostanični karcinom glave i vrata39 studija
- Rak gušterače39 studija
- Rak endometrija38 studija
- Melanom33 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.